StockStory.org on MSN
Life sciences tools & services stocks Q4 earnings: Illumina (NASDAQ:ILMN) firing on all cylinders
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...
Methods developed and validated to establish the "World Bank of NK Cells" from healthy donors and cancer patients -- Single apheresis yields up to 5 billion (5×109) highly pure activated memory ...
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the life sciences tools & services stocks, including 10x Genomics (NASDAQ:TXG) and its peers.
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at PacBio (NASDAQ:PACB) and its peers.
Understand the importance of targeted assays in personalised medicine and how early decisions shape clinical outcomes.
We have developed an integrated microarray production and analysis facility for quantitative comparisons of DNA copy number and RNA expression. The overall process is managed by a custom Oracle ...
Infectious keratitis remains a leading cause of corneal blindness and visual impairment worldwide, with bacterial, fungal, amoebic and viral pathogens presenting major diagnostic and therapeutic ...
Summary: Rising incidence of limb loss due to trauma, diabetes, and vascular diseases, growing adoption of advanced prosthetic technologies, and increasing demand for lightweight, customizable ...
Barclays 28th Annual Global Healthcare Conference March 10, 2026 3:00 PM EDTCompany ParticipantsEmily Leproust ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results